Cite

HARVARD Citation

    Chen, W. et al. (n.d.). Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. Oncogenesis. pp. 1-11. [Online]. 
  
Back to record